Found: 24
Select item for more details and to access through your institution.
FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Gene expression levels of gamma-glutamyl hydrolase in tumor tissues may be a useful biomarker for the proper use of S-1 and tegafur-uracil/leucovorin in preoperative chemoradiotherapy for patients with rectal cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Induction chemotherapy followed by concurrent chemoradiotherapy vs. concurrent chemoradiotherapy for locoregionally advanced nasopharyngeal carcinoma: a retrospective cohort study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Neurotoxicity after high-dose methotrexate (MTX) is adequately explained by insufficient folinic acid rescue.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A prospective comparison of intra-arterial chemotherapy combined with intravesical chemotherapy and intravesical chemotherapy alone after transurethral resection with a thulium laser in high-risk non-muscle invasive bladder cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacodynamic effects in the cerebrospinal fluid of rats after intravenous administration of different asparaginase formulations.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Assessment of drug-drug interaction potential between ceritinib and proton pump inhibitors in healthy subjects and in patients with ALK-positive non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Circularly permuted TRAIL plus thalidomide and dexamethasone versus thalidomide and dexamethasone for relapsed/refractory multiple myeloma: a phase 2 study.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Enhancing the therapeutic range of a targeted small-molecule tubulysin conjugate for folate receptor-based cancer therapy.
- Published in:
- 2017
- By:
- Publication type:
- journal article
UGT1A1 polymorphisms with irinotecan-induced toxicities and treatment outcome in Asians with Lung Cancer: a meta-analysis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 1b study of galunisertib in combination with gemcitabine in Japanese patients with metastatic or locally advanced pancreatic cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Paclitaxel-induced sensory peripheral neuropathy is associated with an ABCB1 single nucleotide polymorphism and older age in Japanese.
- Published in:
- 2017
- By:
- Publication type:
- journal article
In vitro and in vivo assessments of two novel hydrazide compounds against breast cancer as well as mammary tumor cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
MITF suppression by CH5552074 inhibits cell growth in melanoma cells.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Adjuvant concurrent chemoradiotherapy with low-dose daily cisplatin for extrahepatic bile duct cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Hemodialysis does not impact axitinib exposure: clinical case of a patient with metastatic renal cell carcinoma.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase I study of cilengitide and paclitaxel in patients with advanced solid tumors.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The incidence and risk factors of febrile neutropenia in chemotherapy-naïve lung cancer patients receiving etoposide plus platinum.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Accelerating drug development by efficiently using emerging PK/PD data from an adaptable entry-into-human trial: example of lumretuzumab.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Reversing glioma malignancy: a new look at the role of antidepressant drugs as adjuvant therapy for glioblastoma multiforme.
- Published in:
- 2017
- By:
- Publication type:
- journal article
CYT-Rx20 inhibits ovarian cancer cells in vitro and in vivo through oxidative stress-induced DNA damage and cell apoptosis.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetics and safety of carfilzomib in patients with relapsed multiple myeloma and end-stage renal disease (ESRD): an open-label, single-arm, phase I study.
- Published in:
- 2017
- By:
- Publication type:
- journal article